Screening for Colorectal Cancer
- PMID: 33099448
- DOI: 10.1016/j.mcna.2020.08.004
Screening for Colorectal Cancer
Abstract
Colorectal cancer screening is essential to detect and remove premalignant lesions to prevent the development of colorectal cancer. Multiple screening modalities are available, including colonoscopy and stool-based testing. Colonoscopy remains the gold standard for detection and removal of premalignant colorectal lesions. Screening guidelines by the American Cancer Society now recommend initiating screening for all average-risk adults at 45 years old. Family history of colorectal cancer, other cancers, and advanced colon polyps are strong risk factors that must be considered in order to implement earlier testing. Epidemiologic studies continue to show disparities in colorectal cancer incidence and mortality and wide variability in screening rates.
Keywords: Colorectal cancer; Epidemiology; Screening.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure J.J. Karlitz serves as consultant to Exact Sciences Corporation as well as being a consultant and part of the speakers bureau for Myriad Genetics. Dr J.J. Karlitz has an equity position in Gastro Girl.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
